
Internal Reference Number: FOI_9210
Date Request Received: 05/02/2026 00:00:00
Date Request Replied To: 10/02/2026 00:00:00
This response was sent via: By Email
Request Summary: IBD Remote Self‑Testing Pathways
Request Category: Companies
| Question Number 1: I am writing to you to request information under the Freedom of Information Act 2000. Please provide responses to the following three questions: Do you currently have a remote self testing pathway for patients with Inflammatory Bowel Disease (IBD)? | |
| Answer To Question 1: No | |
| Question Number 2: If such a pathway exists, are you using the IBDoc home calprotectin testing system produced by Bühlmann? | |
| Answer To Question 2: N/A | |
| Question Number 3: If you are using IBDoc, are you aware that Bühlmann have formally announced the discontinuation of IBDoc, with production scheduled to cease by the end of 2026? I would be grateful if you could share any documents, internal communications, reports and or policy papers relevant to the above. | |
| Answer To Question 3: N/A | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.